Literature DB >> 1763030

Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase.

H Kinouchi1, C J Epstein, T Mizui, E Carlson, S F Chen, P H Chan.   

Abstract

Oxygen-derived free radicals have been implicated in the pathogenesis of vasogenic edema and infarction caused by ischemia and reperfusion injury. In earlier studies, exogenously supplied liposome-entrapped CuZn superoxide dismutase (CuZn-SOD) ameliorated ischemic brain edema and infarction in rats following focal cerebral ischemia. To ascertain directly the role of SOD in the protection against superoxide radical-induced injury, we measured infarct size and water content 24 hr following focal cerebral ischemia in nontransgenic mice and in transgenic mice bearing the human SOD1 gene. These transgenic mice have 3.1-fold higher cellular CuZn-SOD activity in the brain than do their nontransgenic littermates. We also measured antioxidant levels (reduced glutathione and reduced ascorbate) of contralateral cortex, infarct cortex, surrounding cortex, and striatum. Infarct size and brain edema were significantly decreased in transgenic mice compared with nontransgenic mice. Reduced glutathione and reduced ascorbate levels decreased in the ischemic hemisphere, but levels in surrounding cortex and striatum were significantly higher in transgenic mice than in nontransgenic mice. These results indicate that increased endogenous SOD activity in brain reduces the level of ischemic damage and support the concept that superoxide radicals play an important role in the pathogenesis of infarction and edema following focal cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763030      PMCID: PMC53093          DOI: 10.1073/pnas.88.24.11158

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

2.  Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema.

Authors:  P H Chan; S Longar; R A Fishman
Journal:  Ann Neurol       Date:  1987-06       Impact factor: 10.422

Review 3.  Free radicals and brain damage.

Authors:  B K Siesjö; C D Agardh; F Bengtsson
Journal:  Cerebrovasc Brain Metab Rev       Date:  1989

Review 4.  Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation.

Authors:  E D Hall; J M Braughler
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

5.  Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase.

Authors:  P H Chan; G Y Yang; S F Chen; E Carlson; C J Epstein
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

6.  Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury.

Authors:  T H Liu; J S Beckman; B A Freeman; E L Hogan; C Y Hsu
Journal:  Am J Physiol       Date:  1989-02

7.  Lipid peroxidation in focal cerebral ischemia.

Authors:  Y Kinuta; H Kikuchi; M Ishikawa; M Kimura; Y Itokawa
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

8.  Ascorbate is an outstanding antioxidant in human blood plasma.

Authors:  B Frei; L England; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Morphometric evaluation of brain infarcts in rats and gerbils.

Authors:  E F Lundy; B S Solik; R S Frank; P S Lacy; D J Combs; G B Zelenock; L G D'Alecy
Journal:  J Pharmacol Methods       Date:  1986-11

10.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

Authors:  J B Bederson; L H Pitts; S M Germano; M C Nishimura; R L Davis; H M Bartkowski
Journal:  Stroke       Date:  1986 Nov-Dec       Impact factor: 7.914

View more
  107 in total

Review 1.  Reoxygenation injury of human brain capillary endothelial cells.

Authors:  T Nagashima; S Wu; M Yamaguchi; N Tamaki
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

2.  Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity.

Authors:  M R Niesman; K A Johnson; J S Penn
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

3.  An elevated level of copper zinc superoxide dismutase fails to prevent oxygen induced retinopathy in mice.

Authors:  C Klaeger; L de Sa; A J Klaeger; E J Carlson; W V Good; C J Epstein
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

4.  Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats.

Authors:  S Matsuda; M Umeda; H Uchida; H Kato; Tsutomu Araki
Journal:  J Neural Transm (Vienna)       Date:  2009-02-24       Impact factor: 3.575

5.  Prion protein expression and superoxide dismutase activity.

Authors:  D R Brown; A Besinger
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 6.  Blockade of glutamate excitotoxicity and its clinical applications.

Authors:  K Hirose; P H Chan
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

Review 7.  Mutant CuZn superoxide dismutase in motor neuron disease.

Authors:  M E Gurney; R Liu; J S Althaus; E D Hall; D A Becker
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

8.  Redox status in acute ischemic stroke: correlation with clinical outcome.

Authors:  Dalibor Paspalj; Petar Nikic; Milan Savic; Dragan Djuric; Igor Simanic; Vladimir Zivkovic; Nevena Jeremic; Ivan Srejovic; Vladimir Jakovljevic
Journal:  Mol Cell Biochem       Date:  2015-04-28       Impact factor: 3.396

9.  The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia.

Authors:  Sunghee Cho; Eun-Mi Park; Maria Febbraio; Josef Anrather; Laibaik Park; Gianfranco Racchumi; Roy L Silverstein; Costantino Iadecola
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 10.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.